Is informed consent enough? Monetary incentives for research participation and the integrity of biomedicine

American Journal of Bioethics

Volumn 1, Issue 2, 2001, Pages 49-51

  Kuczewski, Mark ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIOMEDICAL AND BEHAVIORAL RESEARCH; CLINICAL TRIAL; CRITICAL ILLNESS; ECONOMICS; ETHICS; FEE; HUMAN; HUMAN EXPERIMENT; INFORMED CONSENT; MOTIVATION; PERSONNEL; PERSUASIVE COMMUNICATION; RESEARCH SUBJECT; TERMINALLY ILL PATIENT; TRUST; VULNERABLE POPULATION;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

ADULT; CLINICAL TRIALS; COERCION; CRITICAL ILLNESS; ETHICS; FEES AND CHARGES; HUMAN EXPERIMENTATION; HUMANS; INFORMED CONSENT; MOTIVATION; RESEARCH PERSONNEL; RESEARCH SUBJECTS; TERMINALLY ILL; TRUST; VULNERABLE POPULATIONS;

EID: 0035296269     PISSN: 15265161     EISSN: 15360075     Source Type: Journal    
DOI: 10.1162/152651601300169086     Document Type: Article

References (14)

1. Aaronson, N. K., E. Visser-Pol, G. H. Leenhouts et al. 1996. Telephone- based nursing intervention improves the effectiveness ofthe informed consent process in cancer clinical trials. Journal of Clinical Oncology 14(3):984-986.
2. Anonymous 1976. Patient consent given but forgotten. Medical World News 17(4):26.
3. Appelbaum, P. S., L. H. Roth, and C. Lidz 1982. The therapeutic misconception: Informed consent in psychiatric research. International Journal of Law and Psychiatry 5:319-329.
4. Braddock, C. H. III, S. D. Finn, W. Levinson et al. 1997. How doctors and patients discuss routine clinical decisions: Informed decision making in the outpatient setting. Journal of General Internal Medicine 12(6):339-345.
5. Byock, I. 1997. Dying well: Peace and possibilities at the end of life. New York: Riverhead Books
6. Christakis, N. 1999. Death foretold: Prophecy and prognosis in medical care. Chicago: University of Chicago Press.
7. Daugherty, C., M. J. Ratain, E. Grochowski et al. 1995. Perceptions of cancer patients and their physicians involved in Phase I clinical trials. Journal of Clinical Oncology 13(5):1062-1072.
8. Eichenwald, K., and G. Kolata. 1999. Drug trials hide conflicts for doctors. New York Times, 16 May.
9. Grady, C. 2001. Money for research participation: Does it jeopardize informed consent? American Journal of Bioethics 1(2):40-44.
10. Jonsen, A. R., and J. Stryker, eds. 1993. The social impact of AIDS in the United States. Washington: National Academy Press.
11. Minogue, B., G. Palmer-Fernandez et al. 1995. Individual autonomy and the double-blind controlled experiment: The case of desperate volunteers. Journal of Medicine and Philosophy 20:43-55.
12. Pellegrino, E. D., and D. C. Thomasma. 1981. A philosophical basis of medical practice: Toward a philosophy and ethic of the healing professions. New York: Oxford University Press.
13. U.S. Department of Health and Human Services. Office of the Inspector General. 2000. Recruiting human subjects: Pressures in industry- sponsored clinical research. Washington: GPO.
14. Yukimasa, A., K. Nakagawa, K. Hasezawa et al. 1997. Significance of informed consent and truthtelling for quality of life in terminal cancer patients. Radiation Medicine 15(2):133-135.